MS4A6A and central nervous system cancer: Interestingly, MS4A6A is expressed in M2 macrophages and correlates with macrophage infiltration, unfavorable clinical outcome, and poor responses to adjuvant chemotherapy in glioma patients (Zhang et al, 2022).